On May 28, 2026 INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, reported that it will participate in the following scientific and investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies Global Healthcare Conference (New York)
Date: Thursday, June 4
Time: 8:45 AM ET
Format: Fireside Chat
Webcast: https://event.summitcast.com/view/NgCqua4VVQjq9ibVWHVWca/adRiTkvKf4AnDsZYyXatz8
World Orphan Drug Congress (Boston)
Poster Presentation: Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine Date: Thursday, June 11
Time: 12:00 – 12:10 PM ET
A replay of the investor event will be available for 90 days at the link above. Members of INOVIO’s management team will also be conducting one-on-one meetings with investors during the investor conference.
(Press release, Inovio, MAY 28, 2026, View Source [SID1234666145])